brl 42810 has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lamivudine has emerged as another effective first-line therapy for chronic hepatitis B as well as a beneficial treatment option for patients with decompensated hepatitis B cirrhosis." | 2.41 | Therapeutic advances in the management of hepatitis B and hepatitis C. ( Nguyen, MH; Wright, TL, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, TJ | 1 |
| McCrary, M | 1 |
| Tyring, SK | 1 |
| Mutimer, D | 1 |
| Nguyen, MH | 1 |
| Wright, TL | 1 |
2 reviews available for brl 42810 and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chickenpox; Cytomegalovirus Infections; Famciclovir; Fos | 2002 |
Therapeutic advances in the management of hepatitis B and hepatitis C.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis C; H | 2001 |
2 other studies available for brl 42810 and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Famc | 2005 |
Advances in the treatment of viral hepatitis.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Hum | 1998 |